Methodological considerations: Potency tests for ...
Methodological considerations: Potency tests for recombinant adjuvanted RTS,S vaccine Background Adjuvanted recombinant RTS,S-based vaccines have been in clinical evaluation since the late
Download Methodological considerations: Potency tests for ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
fDA Guidance for Industry Dissolution Testing of …
www.dissolutiontech.comfDA Guidance for Industry 1 Dissolution Testing of Immediate Release Solid Oral Dosage forms 7iJis gllidl/I/ce is df'lleloped jar immedil/Ie "lease (lR) dosl/ge j017I1S I/Ild is illtrnded 10 prrruide (/) gel/eml
Physicochemical Properties of Buffers Used in …
www.dissolutiontech.com38 AUUST 2017 T INTRODUCTION he pH of buffered dissolution media is a singularly important parameter for dissolution testing because pH influences drug solubility and dissolution rate (1).
Guideline on non-clinical local tolerance testing of ...
www.ema.europa.euGuideline on non-clinical local tolerance testing of medicinal products EMA/CHMP/SWP/2145/2000 Rev. 1 Page 2/9 Guideline on non-clinical local tolerance testing of
Reflection paper on the dissolution specification for ...
www.ema.europa.eu1.1. Scope In the context of this reflection paper immediate release is identified as at least 75% (Q) of the active substance is dissolved within 45 minutes.
ORIGINAL ARTICLE FORMULATION AND IN VITRO …
www.revistafarmacia.rofarmacia, 2015, vol. 63, 1 111 original article formulation and in vitro release testing of rectal suppositories containing nimesulide anca cecilia nicoarĂ1, radu george cazacincu2*, dumitru lupuleasa1, dalia